News NICE backs Alimera’s three-year uveitis implant An implant developed by Alimera Sciences has been recommended by NICE to treat an inflammatory eye disease that can cau
Partner Content Partner Content Your Latest Ophthalmology News for SMi’s Ophthalmic Drugs 20... Ophthalmic Drugs Conference London
News UK study finds clue to rising cancer rates in younger people A study has found evidence that 11 cancers are becoming more common among young people in England, and points to a main driving factor.
Sales & Marketing Sponsored Using AI-driven synthetic personas to take your insights fur... As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.
